Back to Search
ANDREW DEFAZIO, MD
MD
Obstetrics & Gynecology Physician
NPI: 1568435824IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
231599(NY)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
STATE UNIVERSITY OF NEW YORK AT STONY BROOK, SCHOOL OF MEDICINE
Class of 1999
Research & Publications (20)
Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor.
PMID 19540748·Eur J Cancer·2009
8-other
Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.
PMID 19456219·Twin Res Hum Genet·2009
8-other
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas.
PMID 19193619·Clin Cancer Res·2009
8-other
Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.
PMID 19010816·Mol Cancer Res·2008
8-other
Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer.
PMID 18980987·Clin Cancer Res·2008
7-preclinical
ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.
PMID 18765553·Clin Cancer Res·2008
4-observational
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
PMID 18698038·Clin Cancer Res·2008
8-other
Global gene expression profiles of ovarian surface epithelial cells in vivo.
PMID 18502821·J Mol Endocrinol·2008
7-preclinical
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro.
PMID 18349819·Br J Cancer·2008
8-other
High resolution melting for mutation scanning of TP53 exons 5-8.
PMID 17764544·BMC Cancer·2007
4-observational
Overlapping and distinct expression of progesterone receptors A and B in mouse uterus and mammary gland during the estrous cycle.
PMID 16980438·Endocrinology·2006
7-preclinical
MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma.
PMID 16213010·Gynecol Oncol·2006
7-preclinical
Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer.
PMID 15986428·Int J Cancer·2005
8-other
Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma.
PMID 15084842·Int J Gynecol Pathol·2004
4-observational
Expression of progesterone receptors A and B in the mouse ovary during the estrous cycle.
PMID 15044369·Endocrinology·2004
7-preclinical
Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.
PMID 15001645·J Clin Endocrinol Metab·2004
8-other
Mechanisms underlying episodic gonadotropin-releasing hormone secretion.
PMID 12762999·Front Neuroendocrinol·2003
6-review
Cell proliferation in the normal mouse mammary gland and inhibition by phenylbutyrate.
PMID 12481425·Mol Cancer Ther·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 140 PARK AVE
FLORHAM PARK, NJ 07932 - Phone
- (973) 718-5775
Quick Facts
- NPI
- 1568435824
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile